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ABSTRACT 
The objective was to understand the influence of the surface roughness of lactose 
carriers on the adhesion and dispersion of salmeterol xinafoate (SX) from interactive 
mixtures. The surface roughness of lactose carriers was determined by confocal 
microscopy. Particle images and adhesion forces between SX and lactose particles were 
determined by Atomic Force Microscopy. The dispersion of SX (2.5%) from interactive 
mixtures with lactose was determined using a twin-stage impinger (TSI) with a 
Rotahaler® at an airflow rate of 60L/min. SX was analysed using a validated HPLC 
assay. The RMS Rq of lactose carriers ranged from 0.93-2.84μm, the Fine Particle 
Fraction (FPF) of SX ranged between 4 and 24 percent and average adhesion force 
between a SX and lactose particles ranged between 49 and 134 nN. No direct 
correlation was observed between the RMS Rq of lactose carriers and either the FPF of 
SX for the interactive mixtures or the adhesion force of a SX on the lactose particles; 
however, the presence of fine lactose associated with the carrier surface increased the 
FPF of SX. Dispersion through direct SX detachment from the carrier surface was not 
consistent with the poor correlations described and was more likely to occur through 
complex particulate interactions involving fine lactose. 
INTRODUCTION 
The surface roughness of lactose carriers, a major component of dry powder inhaler 
(DPI) formulations, is likely to affect inter-particulate forces between drug and carrier 
particles, since the surface irregularities on both the carrier and drug particle changes 
the effective area of contact. Such contact changes will influence drug detachment from 
the carrier surface. The effect of surface roughness depends upon the number and size 
of the asperities, the distance between asperity peaks and the relative size of the 
adhering particles (Zimon and Volkova, 1965) and a wide distribution of adhesion 
forces between SX and lactose surfaces was observed due to the roughness of lactose 
particles (Islam et al., 2005). 
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The surface roughness of individual lactose particles has been measured by optical and 
laser profilometry (Podczeck, 1997), atomic force microscopy (Beach et al., 2002), 
laser scanning confocal microscopy (Iida et al., 2003) and recently by scanning white 
light interferometry (Adi et al., 2008a). Fine particles of lactose were reported to change 
the surface roughness of large carriers by corrasion (filling the depressions), which was 
thought to reduce the adhesion force between drug and carriers resulting in an increase 
in the delivery of SX (Podczeck, 1998).  
 
The FPF of salbutamol sulphate (SS) was increased up to an optimum value of surface 
roughness, and then decreased with further increasing roughness determined by AFM 
(Heng et al., 2000). In 2003, Chan et al. demonstrated that increased surface roughness 
of lactose carriers increased deposition of SS and this result contradicted the previous 
study(Chan et al, 2003). In another study, the surface roughness of lactose carriers, 
untreated and treated (with magnesium stearate) lactose, was determined  and a greater 
fine particle dose (FPD) of beclomethasone dipropionate from treated lactose, having a 
lower surface roughness, was observed compared with that of untreated lactose having 
higher surface roughness (Young et al., 2002).  It is unclear whether the decreased 
adhesion was due to the change in surface roughness or to changes in adhesive forces 
such as capillary and van der Waals forces due to the presence or absence of magnesium 
stearate. Very recently, the degree of surface corrugation of engineered bovine serum 
albumin particles measured by AFM was found to influence the aerosolzation 
performance of particles for inhalation (Adi et al., 2008b). The investigators have 
measured the surface roughness of individual particles on the area of 1x1 µm2, which 
may not be the representative area for a drug particle over 1 µm size.  Using the laser 
scanning confocal microscopy (LSCM), the surface roughness of individual lactose 
particles was demonstrated (Iida et al., 2003) and increased deposition of salbutamol 
sulphate with increasing surface roughness of lactose carriers (treated with 70% 
ethanol) occurred up to a maximum level.  The deposition then decreased with 
increasing surface roughness.  
 
In the above discussions, surface roughness of substrates has been shown to affect 
dispersion of a number of drugs. However, the studies are sometimes difficult to 
interpret for a number of reasons. Some of the substrates used with roughness values in 
the nanometer range where inhalation grade lactose carriers used in commercial 
formulations were generally much rougher. Some roughness modifications were made 
using added fine adhered components (lactose and magnesium stearate) and the 
influence of these fine adhered particles on dispersion was not taken into account. 
Therefore, in order to gain a better understanding of carrier roughness effects on 
respiratory drug delivery, this study was designed to measure carrier surface roughness, 
drug dispersion and drug-carrier adhesion for powders for inhalation using SX and 
several inhalation grade lactose carriers. Consideration was given to fine lactose effects 
that are well known to influence dispersion and use was made of a decantation process 
to remove adhered fine lactose particles from the carriers. 
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EXPERIMENTAL 
Materials  
Salmeterol Xinafoate (SX), micronized (inhalation grade; < 4 μm), was obtained from 
GlaxoSmithKline, Australia. Aeroflo 95, Aeroflo 65 and Aeroflo 20, inhalation grades 
of α-lactose monohydrate, were donated by Foremost Farms, USA; Inhalac 70, Inhalac 
120, Inhalac 230 and Sorbolac 400 were donated by Meggle GmbH, Germany; 
Pharmatose 125M & 110M was donated by DMV International, The Netherland; and 
Lactose Special dense, a non inhalation grade was donated by Lactose New Zealand. 
Ammonium acetate (Analar, BDH, Victoria), methanol (HPLC grade, Biolab, Victoria), 
absolute alcohol (HPLC grade, CSR, Victoria) were used as supplied. 
 
Methodology 
Preparation of interactive mixtures and filling of capsules  
Interactive powder mixtures of SX (2.5%) and different grades of lactose (total weight 5 
g) were prepared by a validated hand mixing method (Alway et al., 1996). The powder 
formulations (~ 20.0 mg) were filled into hard gelatin capsules (size 3, Fawns and 
McAllan Pty Ltd., Australia) manually. 
 
Drug dispersion by twin-stage impinger (TSI)  
The in-vitro aerosol deposition of the powder formulations delivered from a Rotahaler® 
(Glaxo Wellcome) was determined using a twin-stage impinger (TSI, Copley, UK). The 
air flow was drawn through the TSI using a vacuum pump (Model OD5/2, Dynavac 
Engineering, Australia) and the air flow rate was adjusted to 60 L min-1 at the 
mouthpiece, prior to each measurement. The FPF was defined as the percent of the 
recovered dose (RD) deposited in the lower stage of the TSI. The RD was the total 
amount of drug collected from inhaler, stage one (S1) and stage two (S2). Five 
replicates of each mixture were performed for TSI measurement and the controlled 
temperature, 21±1°C, and relative humidity of 50±3%, was maintained during this 
study. 
 
HPLC analysis of SX  
SX was analysed by High Performance Liquid Chromatography (HPLC) using a C18 
column (μBondapak™, 3.9 x 300mm, Waters) and a UV detector (Waters Tunable 
Absorbance Detector, USA) at a wavelength of 252 nm. A mixture of methanol and 
0.2% (w/v) ammonium acetate solution (55:45, pH ~6.9) was used as a mobile phase 
running at a flow rate of 1.0 ml min-1. The retention time of SX was 4.5 minutes.  
 
Decantation and removal of fine lactose  
Using absolute ethanol, fine lactose particles were removed from the lactose carrier 
(Aeroflo 65 & 95) by decantation (Islam et al., 2004). These two samples of lactose 
carriers were selected for removing the fine lactose (FL) because these samples showed 
wide particle size distribution and contained a significant amount of FL associated with 
the large carriers.   
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Determination of adhesion forces 
The adhesional properties of different lactose carriers against SX probe were measured 
using atomic force microscopy (AFM) with a colloid probe technique(Ducker et al., 
1991). Details of measuring adhesional properties are demonstrated elsewhere (Islam et 
al., 2005). 
Determination of surface roughness 
Atomic Force Microscope (AFM): Using a Nanoscope III atomic force microscope 
(AFM) (Digital Instruments, CA), TappingMode surface scans were performed in air at 
ambient temperature and humidity using a TappingMode AFM tips, with force 
constants of about 40N/m and resonant frequencies of 300–400 kHz. A defined scan 
size of 10 X 10 µm2 with 512 X 512 points in each image was used. The root mean 
square (RMS) roughness (Rq), and average roughness (Ra) were determined using 
image analysis software available with the AFM.  
Confocal Microscopy: The surface roughness of the lactose carriers was measured by 
confocal microscopy (Leica TCS NT, Leica Microsystems) equipped with ArKr 
(Argon-Krypton) laser (568 nm excitation was used) and 590 LP (long pass) filter for 
detection of fluorescent emission. Both the AFM and confocal techniques were 
validated using a platinum-coated silicon calibration reference surface with pits of 180 
nm. Details of method validation and measuring surface roughness of individual lactose 
particles are demonstrated previously (Islam et al., 2006). 
RESULTS AND DISCUSSIONS 
Surface roughness of lactose carriers  
The surface roughness (RMS Rq) of 25 sample areas from five different particles for the 
different grades of original and decanted lactose carriers ranged from 0.93-2.84 μm.  
Roughness was observed to vary across a single particle but there were only slight 
differences in the range of roughness observed on different particles. For the original 
(un-decanted) lactose carriers, Aeroflo 95 and Sorbolac 400 showed the highest and the 
lowest surface roughness, respectively and a significant difference (ANOVA, p=0.001) 
in the mean RMS Rq among the samples was observed. The determined RMS Rq values 
of the original surfaces might be reduced by the presence of fine lactose associated with 
large carriers.  
Relationship between FPF and RMS Rq 
The FPFs of SX for the 12 formulations ranged between 23.7% (Aeroflo 20) and 3.9% 
(Inhalac 120) with significant (p<0.001) differences in FPF between the different 
lactose carriers. The FPFs were plotted against the respective RMS Rq of those carriers 
(Fig. 1) and no direct correlation between dispersion and surface roughness was evident. 
For example, while carriers that caused the highest dispersion (Aeroflo 20, Aeroflo 65 
and Sorbalac 400) possessed low RMS Rq values and while the decanted Aeroflo 95 
with the greatest surface roughness possessed a low dispersion, there were a group of 
lactose carriers possessing both low roughness and low SX dispersion capabilities.  
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Fig.1. Relationship between Fine Particle Fraction (FPF, n=5) of SX from lactose 
mixtures and roughness (RMS Rq, n=25) of the lactose carriers determined by confocal 
microscopy.   
 
This outcome may have been not unexpected as the carrier contain different 
concentrations of fine lactose and a strong relationship between SX dispersion and 
concentration of fine lactose particles was observed using some of these carriers 
(Aeroflo 95, 65 and 20, Inhalac 120 and 230 and Sorbalac 400) (Islam et al., 2004). A 
similar conclusion can be made with the extended range of carriers used in this study.  
There is a consistent trend between the FPF of SX and the concentration of fine lactose 
less than 5 μm (Figure 2). 
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Fig.2. Relationship between the FPF and concentration of FL associated with the lactose 
carrier (FL< 5 μm) of all lactose carriers investigated (some data reproduced from ref. 
(Islam et al., 2004). 
 
The presence of FL associated with the carrier was seen as a key parameter controlling 
dispersion. Recent studies have demonstrated that the role of FL in dispersion is 
associated with its ability to form SX-FL agglomerates with decreased agglomerate 
strength (Adi et al., 2006). In previous studies, the presence of adhered FL was 
postulated to have an effect on the surface roughness profile by filling up the surface 
discontinuities (Podczeck, 1998, Young et al., 2002). Thus, some relationship might be 
expected between the concentration of FL and surface roughness for the carriers used in 
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this research. This relationship is demonstrated in Figure 3 where concentration of FL 
associated with the carriers is plotted against the carrier RMS Rq.  
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Fig.3. Relationship between percent FL and RMS Rq of lactose carriers (n=25). 
The data were variable, but, in general, as the concentration of fine lactose increased, 
the RMS Rq decreased.  In order for the fine lactose to reduce surface roughness, the 
fine lactose particles must be adhered to the surface and must be able to form multi-
layers within the depressions and valleys on the carrier surface. Multi-layer adhesion 
has been seen (by scanning electron microscope, data not shown) particularly at high 
drug and fine lactose concentrations. It follows that, if the presence of fine lactose 
changed the surface roughness consistent with the data in Fig. 3, then there may be 
some relationship between the surface roughness and the adhesion force of SX particles 
to the lactose surfaces since the contact area between SX particle and lactose surface 
will change with a change in roughness. The adhesion force between an SX particle and 
lactose surface was determined for some of the lactose carriers using the colloid probe 
AFM approach and there was no straightforward relationship between the SX-lactose 
adhesion force for the differing carriers and surface roughness (Fig. 4). This means that 
surface roughness of lactose carriers or the adhesion between SX probe and lactose 
surfaces were not independent in influencing drug detachment from the surfaces. This 
was not surprising since there were likely to be other factors contributing to the 
adhesion including differing inherent adhesion activity of the different lactose carriers 
due to crystal surface disruption, crystal face orientation, amorphous domains and 
adsorbed impurities, and due to more complex orientation considerations at the 
interacting surface. Furthermore the irregular SX probe and the rough surfaces of 
lactose particles might make different contact, and therefore, the measured adhesion 
between SX probe and lactose surfaces may not be representative.  
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Fig. 4: Relationship between surface roughness, and RMS Rq of lactose carriers (n=25) 
and adhesion forces of SX probe and lactose carriers (adhesion force, n=100) 
Relationship between fine particle fraction and adhesion force 
There was also a positive but statistically insignificant relationship between FPF of SX 
and SX-lactose average adhesion forces (Fig. 5). Analysis of the adhesion data in Fig. 5 
showed significant (ANOVA, p<0.05) differences in adhesion force between Inhalac 
120, Aeroflo 95, Aeroflo 20 and Inhalac 230; and between Aeroflo 95 and Sorbolac 
400. Decanted Aeroflo 65 and Aeroflo 95 showed significantly (P<0.001) higher 
adhesion forces compared with all samples. No differences (p<0.05) were observed 
between the others lactose samples.   
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Fig. 5: Relationship between FPF and adhesion forces between SX particle and lactose 
carriers determined by AFM (Adhesion force, n= 90).  Error bars = mean ± SD 
It is informative to consider the influence of decantation process on the relationship 
between surface roughness, adhesion and dispersion for the samples of Aeroflo 65 and 
95. Decantation produced a small increase in the surface roughness of Aeroflo 95, but 
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had little effect on the Aeroflo 65. The slight roughness increase, in the case of Aeroflo 
95, may have been related to the removal of the FL particles from the depressions on the 
carrier surface. However, the influence of the decantation process on surface 
modification cannot be discounted. As can be seen in Fig. 5, decantation caused a 
significant increase in the adhesion force between the SX particle and the lactose 
surfaces for Aeroflo 65 where the roughness change due to decantation was negligible. 
In addition, if the lactose were simply changing surface adhesion characteristics through 
corrasion, then the order of mixing of the drug and lactose should be important.  The 
data in Table 1 demonstrated that there was no significant difference in the FPF of SX 
when either FL or SX were mixed first with the lactose carrier or when both were added 
together.  Clearly, the FL was contributing to dispersion in some way other than by 
smoothing of the surface. 
  
Table 1: Influence of order of mixing on the FPF of SX from interactive mixtures 
containing SX (2.5%), FL (5%) and lactose carrier. Standard deviations are in brackets. 
Lactose sample Order of mixing % FPF 
Decanted 
Aeroflo 65,  
Size fraction, 
90-106 μm 
FL was blended at first with large lactose carriers and 
then SX was mixed with the binary mixtures 
13.76 (2.7) 
SX was blended at first with large lactose carriers and 
then FL was mixed with the binary mixtures 
12.09 (0.7) 
Both FL and SX blended with large carriers at same 
time 
11.28 (0.8) 
 
Assignment of cause of these adhesion changes was uncertain, although, our previous 
studies demonstrated that the surface roughness had significant effect on the distribution 
of SX-lactose adhesion forces (Islam et al., 2005). Given the preceding data, it was 
unlikely to be due to surface roughness changes with resulting changes to the contact 
area. It may be related to effects such as recrystallisation of amorphous lactose domains 
at the surface in the ethanol decantation solution changing the surface crystallinity 
(affects surface free energy which in turn affects adhesive characteristics), or to the 
removal of surface impurities and FL leading to greater numbers of adhering sites 
available for the SX interaction. It was also interesting to note that, for both decanted 
Aeroflo 65 and 95 samples where the FL particles on the surface were removed, there 
was a significant reduction in the FPF of SX. Such a result would be consistent with 
both the “activated site” theory (Zeng et al., 1998) and the “redistribution and mixed 
drug-FL agglomeration” theory (Islam et al., 2004, Louey and Stewart, 2002). For the 
“activated site” theory, the removal of FL by decantation would be seen to provide a 
greater number of higher energy sites available for SX interaction thereby reducing the 
propensity of the SX to be detached from the surface of the lactose, while the 
“redistribution and mixed drug-FL agglomeration” theory would consider the removal 
of FL to minimise the formation of more readily dispersed mixed agglomerates of FL 
and drug. In a previous study, the addition of FL to a decanted sample of Aeroflo 65 and 
95 to restore FL concentrations to original levels, have been shown to increase the 
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dispersion of SX to FPFs seen in the original samples (Islam et al., 2004, Louey and 
Stewart, 2002).  
 
CONCLUSIONS 
In this study, there was an inconclusive relationship between the roughness of several 
inhalation lactose carrier surfaces and both the dispersion of SX from interactive 
mixtures and the adhesion force between SX particle and the lactose carrier surface. The 
presence of FL associated with the lactose carriers had been shown previously to be a 
key parameter in the dispersion process and this current study contributed additional 
evidence to support this unique functionality of the FL.  The research confirmed that the 
SX dispersion process occurring in powder mixtures for inhalation may not just be 
associated with drug detachment from the coarse carrier, but, where particulate loadings 
are high, will involve dispersion mechanisms (such as de-agglomeration) that are not 
associated with the coarse lactose surface.  The surface roughness of interacting 
particles was likely to affect the adhesion force between these particles due to differing 
contact areas. The effect also was likely to be dependent on adhering particle size, 
roughness profile, particle deformation and energy of impact of the particle with the 
surface. In this study, the fact that poor correlations existed between SX dispersion and 
both surface roughness and adhesion force provided further evidence that mechanisms 
beyond drug-carrier detachment were important in the dispersion of interactive drug 
powder mixtures. 
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